C. Darke

3.2k total citations
151 papers, 2.4k citations indexed

About

C. Darke is a scholar working on Immunology, Hematology and Pathology and Forensic Medicine. According to data from OpenAlex, C. Darke has authored 151 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 99 papers in Immunology, 50 papers in Hematology and 17 papers in Pathology and Forensic Medicine. Recurrent topics in C. Darke's work include T-cell and B-cell Immunology (86 papers), Immune Cell Function and Interaction (56 papers) and Immunotherapy and Immune Responses (28 papers). C. Darke is often cited by papers focused on T-cell and B-cell Immunology (86 papers), Immune Cell Function and Interaction (56 papers) and Immunotherapy and Immune Responses (28 papers). C. Darke collaborates with scholars based in United Kingdom, Nigeria and United States. C. Darke's co-authors include M.G. Guttridge, J. Street, Mark Worwood, John Thompson, John H. Lazarus, Matthew A. Brown, R John, B P Wordsworth, A. B. Parkes and Derek Middleton and has published in prestigious journals such as The Lancet, The Journal of Clinical Endocrinology & Metabolism and British Journal of Cancer.

In The Last Decade

C. Darke

142 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. Darke United Kingdom 24 1.1k 700 466 363 277 151 2.4k
Héctor Melín‐Aldana United States 31 590 0.5× 312 0.4× 1.4k 2.9× 115 0.3× 168 0.6× 100 3.6k
J O'donnell New Zealand 27 380 0.3× 255 0.4× 731 1.6× 136 0.4× 208 0.8× 62 1.8k
Robert H. McLean United States 24 647 0.6× 252 0.4× 408 0.9× 160 0.4× 174 0.6× 53 1.4k
Astrid G. S. van Halteren Netherlands 25 1.1k 1.0× 307 0.4× 62 0.1× 280 0.8× 689 2.5× 54 2.3k
Marilyn Campion United States 18 207 0.2× 153 0.2× 335 0.7× 285 0.8× 112 0.4× 25 1.7k
J. Kempeni Germany 15 646 0.6× 509 0.7× 264 0.6× 77 0.2× 95 0.3× 22 1.6k
Irene Lorand‐Metze Brazil 27 488 0.4× 1.2k 1.7× 184 0.4× 70 0.2× 206 0.7× 205 2.5k
Søren Thue Lillevang Denmark 27 606 0.5× 176 0.3× 330 0.7× 94 0.3× 333 1.2× 91 2.3k
P. Bonara Italy 18 329 0.3× 179 0.3× 200 0.4× 276 0.8× 97 0.4× 47 1.2k
H. Kronenberg Australia 20 225 0.2× 832 1.2× 386 0.8× 55 0.2× 162 0.6× 125 1.9k

Countries citing papers authored by C. Darke

Since Specialization
Citations

This map shows the geographic impact of C. Darke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Darke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Darke more than expected).

Fields of papers citing papers by C. Darke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Darke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Darke. The network helps show where C. Darke may publish in the future.

Co-authorship network of co-authors of C. Darke

This figure shows the co-authorship network connecting the top 25 collaborators of C. Darke. A scholar is included among the top collaborators of C. Darke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Darke. C. Darke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Street, J., et al.. (2009). A new HLA‐B*08 variant ‐ B*0838. Tissue Antigens. 73(4). 373–374. 2 indexed citations
2.
Vilariño‐Güell, Carles, Iannis E. Adamopoulos, Robert Lawrence, et al.. (2008). Fine mapping of the MHC Class III region demonstrates association of AIF1 and rheumatoid arthritis. Lara D. Veeken. 47(12). 1761–1767. 35 indexed citations
5.
Guttridge, M.G., et al.. (2004). Five-Locus HLA Typing of Hematopoietic Stem Cell Donor Volunteers Using PCR Sequence Specific Primers. Genetic Testing. 8(3). 301–312. 24 indexed citations
6.
Brown, Matthew A., et al.. (2002). HLA-DR/DQ haplotype in rheumatoid arthritis: Novel allelic associations in UK Caucasians. QUT ePrints (Queensland University of Technology). 11 indexed citations
7.
Guttridge, M.G., Kymberley Carter, Mark Worwood, & C. Darke. (2000). Population Screening for Hemochromatosis by PCR Using Sequence-Specific Primers. Genetic Testing. 4(2). 111–114. 8 indexed citations
8.
Darke, C.. (2000). An overview of the Welsh Bone Marrow Donor Registry: 10 years of bone marrow donor provision. Bone Marrow Transplantation. 25(7). 771–777. 32 indexed citations
9.
Darke, C., M.G. Guttridge, J. Street, John Thompson, & Muriel Thomas. (2000). Molecular, serological and genetic studies on two new HLA‐DRB1 alleles – HLA‐DRB1*0704 and HLA‐DRB1*1507. Tissue Antigens. 56(5). 467–469. 7 indexed citations
10.
Maxwell, Alexander P., Damian Fogarty, Derek Middleton, et al.. (1998). AN INTERLUEKIN 1B ALLELE, WHICH CORRELATES WITH A HIGH SECRETOR PHENOTYPE, IS ASSOCIATED WITH DIABETIC NEPHROPATHY. Cytokine. 10(12). 984–988. 43 indexed citations
11.
Hall, Frances, Daniel E. Weeks, J. Camilleri, et al.. (1996). Influence of the HLA-DRB1 locus on susceptibility and severity in rheumatoid arthritis. QJM. 89(11). 821–830. 64 indexed citations
12.
Parkes, Arthur B., C. Darke, Soufiane Ben Othman, et al.. (1996). Major histocompatibility complex class II and complement polymorphisms in postpartum thyroiditis. European Journal of Endocrinology. 134(4). 449–453. 17 indexed citations
13.
Worwood, Mark, M. Tevfik Dorak, Stuart A. Nicklin, et al.. (1996). The frequency of the haemochromatosis‐associated genotype D6S265‐1:D6S105‐8 in blood donors. British Journal of Haematology. 93(4). 838–840. 8 indexed citations
14.
Arnett, Kelly L., Erin J. Adams, Jenny E. Gumperz, et al.. (1995). Expression of an unusual Bw4 epitope by a subtype of HLA‐B8 [B*0802]. Tissue Antigens. 46(4). 316–321. 13 indexed citations
15.
Middleton, Derek, et al.. (1994). TAP1 and TAP2 polymorphism in multiple sclerosis patients. Human Immunology. 40(2). 131–134. 19 indexed citations
16.
Worwood, Mark & C. Darke. (1993). Serum ferritin, blood donation, iron stores and haemochromatosis. Transfusion Medicine. 3(1). 21–28. 18 indexed citations
17.
Ratanachaiyavong, Suvina, et al.. (1990). DQA2 U ALLELE: A GENETIC MARKER FOR RELAPSE OF Graves'DISEASE. Clinical Endocrinology. 32(2). 241–251. 15 indexed citations
18.
Amer, Amal O., G. Singh, C. Darke, & A. E. Dolby. (1990). Spontaneous lymphocyte proliferation in severe periodontal disease: role of T and B cells. Journal of Oral Pathology and Medicine. 19(1). 49–52. 11 indexed citations
19.
Cragg, S. J., C. Darke, & Mark Worwood. (1988). HLA class I and H ferritin gene polymorphisms in normal subjects and patients with haemochromatosis. Human Genetics. 80(1). 63–68. 15 indexed citations
20.
Toll, D. G., et al.. (1973). Linkage Study on the ‘Ridges-off-the-End’ and Nelson Syndromes. Human Heredity. 23(3). 280–287. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026